@Raphcarroll I don't think you'll be disappointed from...

@Raphcarroll I don't think you'll be disappointed from holding onto this one. it's a long time to be holding and not seeing any reward in price movement but I commend you for holding. I think the fundamentals with this company are very strong.
a tightly held share registry combined with strong pipeline of activity. management have an large invested holding and we've got cash reserves to hold us for another 2/3 years. The human clinical trial announcements coming out thus far have been nothing but supportive of the in-vivo trails we have to date.

I think we're in the best possible position coming into 2022.